Case Control Study
Copyright ©The Author(s) 2023.
World J Gastrointest Pathophysiol. Mar 22, 2023; 14(2): 21-33
Published online Mar 22, 2023. doi: 10.4291/wjgp.v14.i2.21
Table 2 Relationship between serum anti-Opisthorchis viverrini and cholangiocarcinoma risk, Ubon Ratchathani, Thailand
Number of case-control pairs according to serum anti-OV status: positive (+) vs negative (-)
Crude OR
95%CI
P value
Adjusted1 OR
95%CI
P value
Adjusted2 OR
95%CI
P value
Case (+) / Control (+)
Case (+) / Control (-)
Case (-) / Control (+)
Case (-) / Control (-)
LL
UL
LL
UL
LL
UL
67232311.50 2.71 48.78 < 0.0018.96 2.06 38.99 0.0019.40 2.16 40.85 0.003

  • Citation: You G, Zeng L, Tanaka H, Ohta E, Fujii T, Ohshima K, Tanaka M, Hamajima N, Viwatthanasittiphong C, Muangphot M, Chenvidhya D, Jedpiyawongse A, Sripa B, Miwa M, Honjo S. Polymorphism of genes encoding drug-metabolizing and inflammation-related enzymes for susceptibility to cholangiocarcinoma in Thailand. World J Gastrointest Pathophysiol 2023; 14(2): 21-33
  • URL: https://www.wjgnet.com/2150-5330/full/v14/i2/21.htm
  • DOI: https://dx.doi.org/10.4291/wjgp.v14.i2.21